Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP

Blood (2010) 116 (21): 2005.

https://doi.org/10.1182/blood.V116.21.2005.2005

Published: 2010

Journal Articles

Recurrent DNA Mutations In Non-Hodgkin Lymphomas Reveal Candidate Therapeutic Targets

Blood (2010) 116 (21): 632.

https://doi.org/10.1182/blood.V116.21.632.632

Published: 2010

Journal Articles

Identification of Genes Frequently Mutated In FL and DLBCL with Transcriptome, Genome and Exome Sequencing

Blood (2010) 116 (21): 804.

https://doi.org/10.1182/blood.V116.21.804.804

Published: 2010

Journal Articles

Mutations In MLL2 and MEF2B Genes In Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

Blood (2010) 116 (21): 473.

https://doi.org/10.1182/blood.V116.21.473.473

Published: 2010

Journal Articles

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

Christian Steidl, Adele Telenius, Sohrab P. Shah, Pedro Farinha, Lorena Barclay, Merrill Boyle, Joseph M. Connors, Douglas E. Horsman, Randy D. Gascoyne

Blood (2010) 116 (3): 418–427.

https://doi.org/10.1182/blood-2009-12-257345

Published: 2010

Includes: Supplemental data

Journal Articles

MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL.

Blood (2009) 114 (22): 1100.

https://doi.org/10.1182/blood.V114.22.1100.1100

Published: 2009

Journal Articles

TNFRSF14 Is Mutated in a Subset of Follicular Lymphoma and Correlated with Inferior Prognosis.

Blood (2009) 114 (22): 1919.

https://doi.org/10.1182/blood.V114.22.1919.1919

Published: 2009

Journal Articles

FAS Mutations in Follicular Lymphoma Are Rare but Associated with Aggressive Clinical Behavior.

Nathalie A. Johnson, MD, Ryan Morin, PhD, Tesa Severson, M.Sc., Andrew J. Mungall, Ph.D., Yongjun Zhao, Jacqueline E. Schein, M.Sc., Merrill Boyle, Bruce Woolcock, PhD, Richard Moore, Ph.D., Robert Holt, Douglas E. Horsman, Joseph M. Connors, Steven Jones, Martin Hirst, Marco A Marra, Randy D. Gascoyne, MD

Blood (2009) 114 (22): 3967.

https://doi.org/10.1182/blood.V114.22.3967.3967

Published: 2009

Journal Articles

Base-Pair Resolution of Somatic and Germline-Derived Genome Rearrangement Breakpoints in Follicular Lymphoma.

Blood (2009) 114 (22): 439.

https://doi.org/10.1182/blood.V114.22.439.439

Published: 2009

Journal Articles

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

Kerry J. Savage, Nathalie A. Johnson, Susana Ben-Neriah, Joseph M. Connors, Laurie H. Sehn, Pedro Farinha, Douglas E. Horsman, Randy D. Gascoyne

Blood (2009) 114 (17): 3533–3537.

https://doi.org/10.1182/blood-2009-05-220095

Published: 2009

Journal Articles

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

Nathalie A. Johnson, Kerry J. Savage, Olga Ludkovski, Susana Ben-Neriah, Ryan Woods, Christian Steidl, Martin J. S. Dyer, Reiner Siebert, John Kuruvilla, Richard Klasa, Joseph M. Connors, Randy D. Gascoyne, Douglas E. Horsman

Blood (2009) 114 (11): 2273–2279.

https://doi.org/10.1182/blood-2009-03-212191

Published: 2009

Includes: Supplemental data

Journal Articles

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13

Donna Reece, Kevin W. Song, Tommy Fu, Birgitte Roland, Hong Chang, Douglas E. Horsman, Adnan Mansoor, Christine Chen, Esther Masih-Khan, Young Trieu, Helene Bruyere, Douglas A. Stewart, Nizar J. Bahlis

Blood (2009) 114 (3): 522–525.

https://doi.org/10.1182/blood-2008-12-193458

Published: 2009

Journal Articles

The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL

Weimin Ci, Jose M. Polo, Leandro Cerchietti, Rita Shaknovich, Ling Wang, Shao Ning Yang, Kenny Ye, Pedro Farinha, Douglas E. Horsman, Randy D. Gascoyne, Olivier Elemento, Ari Melnick

Blood (2009) 113 (22): 5536–5548.

https://doi.org/10.1182/blood-2008-12-193037

Published: 2009

Includes: Supplemental data

Journal Articles

Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances

K.-John J. Cheung, Sohrab P. Shah, Christian Steidl, Nathalie Johnson, Thomas Relander, Adele Telenius, Betty Lai, Kevin P. Murphy, Wan Lam, Abdulwahab J. Al-Tourah, Joseph M. Connors, Raymond T. Ng, Randy D. Gascoyne, Douglas E. Horsman

Blood (2009) 113 (1): 137–148.

https://doi.org/10.1182/blood-2008-02-140616

Published: 2009

Includes: Supplemental data

Journal Articles

Genetic Alterations Detected by High-Resolution Array Comparative Genomic Hybridization in Microdissected HRS Cells Correlate with Treatment Outcome in Classical Hodgkin Lymphoma

Christian Steidl, Adele Telenius, Sohrab P. Shah, K-John Cheung, Lorena Barclay, Joseph M. Connors, Douglas E. Horsman, Randy D. Gascoyne

Blood (2008) 112 (11): 522.

https://doi.org/10.1182/blood.V112.11.522.522

Published: 2008

Journal Articles

Deletion in Chromosome 17p12 and Gains in Chromosome 9q33.3 by Array Comparative Hybridization Are Associated with R-CHOP Treatment Failure in Patients with Diffuse Large B Cell Lymphoma

Nathalie Johnson, MD, Ronald J De Leeuw, Julia Chae, Sohrab P Shah, Wan L Lam, Thomas Relander, Joseph M. Connors, MD, Douglas E. Horsman, MD, Randy D. Gascoyne, MD

Blood (2008) 112 (11): 477.

https://doi.org/10.1182/blood.V112.11.477.477

Published: 2008

Journal Articles

Lymphomas with Concurrent T(14;18) and 8q24 Translocations Are Under- Reported and Clinical Outcome Depends on the MYC Partner

Nathalie A Johnson, MD, Kerry J. Savage, MD, Susanna Ben-Neriah, Christian Steidl, MD, Richard Klasa, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Douglas E. Horsman, MD

Blood (2008) 112 (11): 804.

https://doi.org/10.1182/blood.V112.11.804.804

Published: 2008

Journal Articles

High-resolution whole genome tiling path array CGH analysis of CD34 + cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival

Daniel T. Starczynowski, Suzanne Vercauteren, Adele Telenius, Sandy Sung, Kaoru Tohyama, Angela Brooks-Wilson, John J. Spinelli, Connie J. Eaves, Allen C. Eaves, Douglas E. Horsman, Wan L. Lam, Aly Karsan

Blood (2008) 112 (8): 3412–3424.

https://doi.org/10.1182/blood-2007-11-122028

Published: 2008

Includes: Supplemental data

Journal Articles

High Frequency of 1p36.32 Deletion or Loss of Heterozygosity in Follicular Lymphoma (FL).

K.-John Cheung, MSc, Adele Telenius, Betty Lai, Nathalie Johnson, MD, Thomas Relander, MD, Christian Steidl, MD, Agnes Baross, PhD, Hong Qian, Jacquie Schein, PhD, Marco Marra, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Douglas E. Horsman, MD

Blood (2007) 110 (11): 183.

https://doi.org/10.1182/blood.V110.11.183.183

Published: 2007

Journal Articles

High-Resolution CGH Analysis of CD34+ Cells from Lower-Risk Myelodysplastic Patients Reveals Cryptic Copy Number Alterations and Predicts Overall and Leukemia-Free Survival.

Daniel T. Starczynowski, PhD, Suzanne Vercauteren, MD, Adele Telenius, Sandy Sung, Kaoru Tohyama, MD, PhD, Angela Brooks-Wilson, PhD, John J. Spinelli, PhD, Connie J. Eaves, PhD, Allen C. Eaves, MD, PhD, Douglas E. Horsman, MD, Wan L. Lam, PhD, Aly Karsan, MD

Blood (2007) 110 (11): 2431.

https://doi.org/10.1182/blood.V110.11.2431.2431

Published: 2007

NARROW

Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP

Recurrent DNA Mutations In Non-Hodgkin Lymphomas Reveal Candidate Therapeutic Targets

Identification of Genes Frequently Mutated In FL and DLBCL with Transcriptome, Genome and Exome Sequencing

Mutations In MLL2 and MEF2B Genes In Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL.

TNFRSF14 Is Mutated in a Subset of Follicular Lymphoma and Correlated with Inferior Prognosis.

FAS Mutations in Follicular Lymphoma Are Rare but Associated with Aggressive Clinical Behavior.

Base-Pair Resolution of Somatic and Germline-Derived Genome Rearrangement Breakpoints in Follicular Lymphoma.

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13

The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL

Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances

Genetic Alterations Detected by High-Resolution Array Comparative Genomic Hybridization in Microdissected HRS Cells Correlate with Treatment Outcome in Classical Hodgkin Lymphoma

Deletion in Chromosome 17p12 and Gains in Chromosome 9q33.3 by Array Comparative Hybridization Are Associated with R-CHOP Treatment Failure in Patients with Diffuse Large B Cell Lymphoma

Lymphomas with Concurrent T(14;18) and 8q24 Translocations Are Under- Reported and Clinical Outcome Depends on the MYC Partner

High-resolution whole genome tiling path array CGH analysis of CD34 + cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival

High Frequency of 1p36.32 Deletion or Loss of Heterozygosity in Follicular Lymphoma (FL).

High-Resolution CGH Analysis of CD34+ Cells from Lower-Risk Myelodysplastic Patients Reveals Cryptic Copy Number Alterations and Predicts Overall and Leukemia-Free Survival.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only